These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 12714271)
1. Seeking SOCS and sex steroids. Waters MJ Trends Endocrinol Metab; 2003; 14(4):149-51. PubMed ID: 12714271 [TBL] [Abstract][Full Text] [Related]
2. Differential expression of suppressors of cytokine signalling genes in response to nutrition and growth hormone in the septic rat. Johnson TS; O'Leary M; Justice SK; Maamra M; Zarkesh-Esfahani SH; Furlanetto R; Preedy VR; Hinds CJ; El Nahas AM; Ross RJ J Endocrinol; 2001 May; 169(2):409-15. PubMed ID: 11312157 [TBL] [Abstract][Full Text] [Related]
3. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Leung KC; Doyle N; Ballesteros M; Sjogren K; Watts CK; Low TH; Leong GM; Ross RJ; Ho KK Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1016-21. PubMed ID: 12552091 [TBL] [Abstract][Full Text] [Related]
4. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). Greenhalgh CJ; Bertolino P; Asa SL; Metcalf D; Corbin JE; Adams TE; Davey HW; Nicola NA; Hilton DJ; Alexander WS Mol Endocrinol; 2002 Jun; 16(6):1394-406. PubMed ID: 12040024 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of growth hormone-induced liver suppressors of cytokine signaling messenger ribonucleic acid by cytokines. Colson A; Le Cam A; Maiter D; Edery M; Thissen JP Endocrinology; 2000 Oct; 141(10):3687-95. PubMed ID: 11014223 [TBL] [Abstract][Full Text] [Related]
6. Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation. Miller ME; Michaylira CZ; Simmons JG; Ney DM; Dahly EM; Heath JK; Lund PK Gastroenterology; 2004 Aug; 127(2):570-81. PubMed ID: 15300589 [TBL] [Abstract][Full Text] [Related]
7. Inflammatory cytokines and the GH/IGF-I axis: novel actions on bone growth. Pass C; MacRae VE; Ahmed SF; Farquharson C Cell Biochem Funct; 2009 Apr; 27(3):119-27. PubMed ID: 19330796 [TBL] [Abstract][Full Text] [Related]
9. Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling. Greenhalgh CJ; Metcalf D; Thaus AL; Corbin JE; Uren R; Morgan PO; Fabri LJ; Zhang JG; Martin HM; Willson TA; Billestrup N; Nicola NA; Baca M; Alexander WS; Hilton DJ J Biol Chem; 2002 Oct; 277(43):40181-4. PubMed ID: 12208853 [TBL] [Abstract][Full Text] [Related]
10. The effect of suppressor of cytokine signaling 3 on GH signaling in beta-cells. Rønn SG; Hansen JA; Lindberg K; Karlsen AE; Billestrup N Mol Endocrinol; 2002 Sep; 16(9):2124-34. PubMed ID: 12198248 [TBL] [Abstract][Full Text] [Related]
11. Expression of SOCS genes in normal and leukemic human leukocytes stimulated by prolactin, growth hormone and cytokines. Dogusan Z; Hooghe-Peters EL; Berus D; Velkeniers B; Hooghe R J Neuroimmunol; 2000 Sep; 109(1):34-9. PubMed ID: 10969179 [TBL] [Abstract][Full Text] [Related]
12. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling. Yumet G; Shumate ML; Bryant DP; Lang CH; Cooney RN Crit Care Med; 2006 May; 34(5):1420-7. PubMed ID: 16540952 [TBL] [Abstract][Full Text] [Related]
13. Sex steroids and the GH axis: Implications for the management of hypopituitarism. Birzniece V; Ho KKY Best Pract Res Clin Endocrinol Metab; 2017 Feb; 31(1):59-69. PubMed ID: 28477733 [TBL] [Abstract][Full Text] [Related]
14. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling. Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778 [TBL] [Abstract][Full Text] [Related]
15. Type II SOCS as a feedback repressor for GH-induced Igf1 expression in carp hepatocytes. Jiang X; Xiao J; He M; Ma A; Wong AO J Endocrinol; 2016 May; 229(2):171-86. PubMed ID: 27271287 [TBL] [Abstract][Full Text] [Related]
16. STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver. Davey HW; McLachlan MJ; Wilkins RJ; Hilton DJ; Adams TE Mol Cell Endocrinol; 1999 Dec; 158(1-2):111-6. PubMed ID: 10630411 [TBL] [Abstract][Full Text] [Related]
17. Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat. Tollet-Egnell P; Flores-Morales A; Stavréus-Evers A; Sahlin L; Norstedt G Endocrinology; 1999 Aug; 140(8):3693-704. PubMed ID: 10433229 [TBL] [Abstract][Full Text] [Related]
18. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects. Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548 [TBL] [Abstract][Full Text] [Related]
19. Estrogen up-regulates hepatic expression of suppressors of cytokine signaling-2 and -3 in vivo and in vitro. Leong GM; Moverare S; Brce J; Doyle N; Sjögren K; Dahlman-Wright K; Gustafsson JA; Ho KK; Ohlsson C; Leung KC Endocrinology; 2004 Dec; 145(12):5525-31. PubMed ID: 15319356 [TBL] [Abstract][Full Text] [Related]
20. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]